The opposing effects of n-3 and n-6 fatty acids

Progress in Lipid Research
Gerd Schmitz, Josef Ecker

Abstract

Polyunsaturated fatty acids (PUFAs) can be classified in n-3 fatty acids and n-6 fatty acids, and in westernized diet the predominant dietary PUFAs are n-6 fatty acids. Both types of fatty acids are precursors of signaling molecules with opposing effects, that modulate membrane microdomain composition, receptor signaling and gene expression. The predominant n-6 fatty acid is arachidonic acid, which is converted to prostaglandins, leukotrienes and other lipoxygenase or cyclooxygenase products. These products are important regulators of cellular functions with inflammatory, atherogenic and prothrombotic effects. Typical n-3 fatty acids are docosahexaenoic acid and eicosapentaenoic acid, which are competitive substrates for the enzymes and products of arachidonic acid metabolism. Docosahexaenoic acid- and eicosapentaenoic acid-derived eicosanoids antagonize the pro-inflammatory effects of n-6 fatty acids. n-3 and n-6 fatty acids are ligands/modulators for the nuclear receptors NFkappaB, PPAR and SREBP-1c, which control various genes of inflammatory signaling and lipid metabolism. n-3 Fatty acids down-regulate inflammatory genes and lipid synthesis, and stimulate fatty acid degradation. In addition, the n-3/n-6 PUFA content of cell...Continue Reading

References

Jan 1, 1986·Progress in Lipid Research·P C WeberT Strasser
Feb 1, 1993·The Journal of Clinical Investigation·R I SperlingD R Robinson
Aug 17, 1999·Annual Review of Nutrition·D B Jump, S D Clarke
Dec 1, 2001·Science·A ChawlaD J Mangelsdorf
Jan 10, 2002·Biochemical and Biophysical Research Communications·I VachierC Chavis
May 8, 2002·The Journal of Clinical Investigation·Jay D HortonMichael S Brown
Jun 5, 2002·Current Opinion in Lipidology·Miguel A Contreras, Stanley I Rapoport
Jul 8, 2003·Carcinogenesis·Yang-Yi FanRobert S Chapkin
Aug 2, 2003·Nature Cell Biology·Teymuras V Kurzchalia, Samuel Ward
Aug 19, 2003·The Journal of Biological Chemistry·Victor L MarcheselliNicolas G Bazan
Dec 5, 2003·Progress in Lipid Research·Rosalind A Coleman, Douglas P Lee
May 14, 2004·Annual Review of Biophysics and Biomolecular Structure·Kai Simons, Winchil L C Vaz
May 18, 2004·The Journal of Clinical Investigation·Mitsuhiro WatanabeJohan Auwerx
May 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Pranab K MukherjeeNicolas G Bazan
Aug 1, 1997·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·C CouetF Lamisse
Dec 8, 2004·Archives of Biochemistry and Biophysics·Martin Spiecker, James K Liao
Mar 9, 2005·The Journal of Experimental Medicine·Makoto AritaCharles N Serhan
Jun 1, 2005·Biochimica Et Biophysica Acta·Gerd Schmitz, Thomas Langmann
Jun 7, 2005·Nature Medicine·Stephen M Prescott, William F Stenson
Jun 18, 2005·Memórias do Instituto Oswaldo Cruz·Patrícia T Bozza, Christianne Bandeira-Melo
Jul 12, 2005·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Charles N Serhan
Jul 26, 2005·Current Opinion in Structural Biology·Scott E Feller, Klaus Gawrisch
Jul 26, 2005·Proceedings of the National Academy of Sciences of the United States of America·Mohammed AkbarHee-Yong Kim
Sep 1, 2005·European Journal of Nutrition·Q LiJ Li
Sep 22, 2005·Journal of the American Chemical Society·Olivier Soubias, Klaus Gawrisch
Oct 11, 2005·Annual Review of Cell and Developmental Biology·Joseph R Marszalek, Harvey F Lodish
Jul 11, 2006·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Philip C Calder

❮ Previous
Next ❯

Citations

Jan 29, 2010·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·B Melnik
Oct 30, 2012·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·A Casado-DíazJ M Quesada-Gómez
Nov 17, 2010·Analytical and Bioanalytical Chemistry·Carlos Ferreiro-VeraMaría Dolores Luque de Castro
Mar 2, 2011·Pflügers Archiv : European journal of physiology·Mauricio A RetamalLuis Reuss
Mar 9, 2012·Genes & Nutrition·Claudio De FeliceJoussef Hayek
Jun 25, 2013·Journal of Physiology and Biochemistry·Silvia Lorente-CebriánMaría J Moreno-Aliaga
Aug 19, 2011·The British Journal of Nutrition·Sunghee LeeAkira Sekikawa
Aug 4, 2011·The British Journal of Nutrition·Sine Nygaard LangerhuusCharlotte Lauridsen
Jun 2, 2011·Chemical Reviews·Rosalind A Coleman, Douglas G Mashek
Feb 6, 2009·Nature Clinical Practice. Neurology·Lahar R MehtaSteven R Schwid
Dec 5, 2012·Nature Reviews. Clinical Oncology·Kenneth FearonVickie Baracos
Aug 25, 2010·The Journal of Biological Chemistry·Cosima ArnoldWolf-Hagen Schunck
Aug 28, 2012·Journal of Biochemistry·Makoto Arita
Jan 19, 2013·Inflammatory Bowel Diseases·Rachel Marion-LetellierSubrata Ghosh
Nov 27, 2009·Journal of the Royal Society, Interface·Jens A LundbaekOlaf S Andersen
Feb 11, 2011·Science Translational Medicine·Przemyslaw SapiehaLois E H Smith
Jul 19, 2013·Annual Review of Nutrition·E Scorletti, C D Byrne
Aug 25, 2012·Pulmonary Medicine·Joshua LawrenzRichard C Baybutt
May 10, 2012·Journal of Nutrition and Metabolism·E PattersonC Stanton
Aug 12, 2009·Lipids in Health and Disease·Breanne M Anderson, David W L Ma
Dec 26, 2013·Arthritis Research & Therapy·Andreea Ioan-Facsinay, Margreet Kloppenburg

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here